 |
PDBsum entry 2tmp
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Metalloprotease inhibitor
|
PDB id
|
|
|
|
2tmp
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Metalloprotease inhibitor
|
 |
|
Title:
|
 |
N-terminal domain of tissue inhibitor of metalloproteinase-2 (n-timp- 2), nmr, 49 structures
|
|
Structure:
|
 |
Tissue inhibitor of metalloproteinases-2. Chain: a. Fragment: n-terminal domain, residues 1-127. Synonym: metalloproteinase inhibitor, timp-2. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Expression_system_variant: de3. Other_details: protein refolded from inclusion bodies
|
|
NMR struc:
|
 |
49 models
|
 |
|
Authors:
|
 |
F.W.Muskett,T.A.Frenkiel,J.Feeney,R.B.Freedman,M.D.Carr, R.A.Williamson
|
Key ref:
|
 |
F.W.Muskett
et al.
(1998).
High resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3.
J Biol Chem,
273,
21736-21743.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
26-May-98
|
Release date:
|
09-Dec-98
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P16035
(TIMP2_HUMAN) -
Metalloproteinase inhibitor 2 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
220 a.a.
127 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
273:21736-21743
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
High resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3.
|
|
F.W.Muskett,
T.A.Frenkiel,
J.Feeney,
R.B.Freedman,
M.D.Carr,
R.A.Williamson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The high resolution structure of the N-terminal domain of tissue inhibitor of
metalloproteinases-2 (N-TIMP-2) in solution has been determined using
multidimensional heteronuclear NMR spectroscopy, with the structural
calculations based on an extensive set of constraints, including 3132 nuclear
Overhauser effect-based distance constraints, 56 hydrogen bond constraints, and
220 torsion angle constraints (an average of 26.9 constraints/residue). The core
of the protein consists of a five-stranded beta-barrel that is homologous to the
beta-barrel found in the oligosaccharide/oligonucleotide binding protein fold.
The binding site for the catalytic domain of matrix metalloproteinases-3
(N-MMP-3) on N-TIMP-2 has been mapped by determining the changes in chemical
shifts on complex formation for signals from the protein backbone (15N, 13C, and
1H). This approach identified a discrete N-MMP-3 binding site on N-TIMP-2
composed of the N terminus of the protein and the loops between beta-strands AB,
CD, and EF. The beta-hairpin formed from strands A and B in N-TIMP-2 is
significantly longer than the equivalent structure in TIMP-1, allowing it to
make more extensive binding interactions with the MMP catalytic domain. A
detailed comparison of the N-TIMP-2 structure with that of TIMP-1 bound to
N-MMP-3 (Gomis-Ruth, F.-X., Maskos, K., Betz, M., Bergner, A., Huber, R.,
Suzuki, K., Yoshida, N., Nagase, H. , Brew, K., Bourne, G. P., Bartunik, H.
& Bode, W. (1997) Nature 389, 77-80) revealed that the core beta-barrels are
very similar in topology but that the loop connecting beta-strands CD (P67-C72)
would need to undergo a large conformational change for TIMP-2 to bind in a
similar manner to TIMP-1.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. Ramachandran plot of the 49 converged structures
of N-TIMP 2. All residues are shown except Pro and Gly.
|
 |
Figure 6.
Fig. 6. A view of the protein backbone for N-TIMP-2
(blue) and the N-MMP-3·TIMP-1 complex (red and white)
showing the differences in structure between the bound and
unbound forms of TIMP at the TIMP/MMP interaction site. The TIMP
structures were superimposed using the coordinates of equivalent
backbone atoms in the -barrel, and
only the N-terminal domain of TIMP-1 is shown. The two zinc ions
of the MMP-3 catalytic domain are shown in magenta (catalytic
site zinc lower left). On the right-hand side of the figure the
AB loop of TIMP-2 can clearly be seen extending far beyond the
TIMP-1 AB loop to make numerous van der Waals clashes with the
N-MMP-3 molecule. The difference in structure of the CD loops
can be seen in the center of the figure. This figure was
produced using MOLMOL (39).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(1998,
273,
21736-21743)
copyright 1998.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.Brew,
and
H.Nagase
(2010).
The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.
|
| |
Biochim Biophys Acta,
1803,
55-71.
|
 |
|
|
|
|
 |
V.Veverka,
A.J.Henry,
P.M.Slocombe,
A.Ventom,
B.Mulloy,
F.W.Muskett,
M.Muzylak,
K.Greenslade,
A.Moore,
L.Zhang,
J.Gong,
X.Qian,
C.Paszty,
R.J.Taylor,
M.K.Robinson,
and
M.D.Carr
(2009).
Characterization of the Structural Features and Interactions of Sclerostin: MOLECULAR INSIGHT INTO A KEY REGULATOR OF Wnt-MEDIATED BONE FORMATION.
|
| |
J Biol Chem,
284,
10890-10900.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.M.Liénard,
G.Garau,
L.Horsfall,
A.I.Karsisiotis,
C.Damblon,
P.Lassaux,
C.Papamicael,
G.C.Roberts,
M.Galleni,
O.Dideberg,
J.M.Frère,
and
C.J.Schofield
(2008).
Structural basis for the broad-spectrum inhibition of metallo-beta-lactamases by thiols.
|
| |
Org Biomol Chem,
6,
2282-2294.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Melendez-Zajgla,
L.Del Pozo,
G.Ceballos,
and
V.Maldonado
(2008).
Tissue inhibitor of metalloproteinases-4. The road less traveled.
|
| |
Mol Cancer,
7,
85.
|
 |
|
|
|
|
 |
R.A.Williamson,
P.Panagiotidou,
J.D.Mott,
and
M.J.Howard
(2008).
Dynamic characterisation of the netrin-like domain of human type 1 procollagen C-proteinase enhancer and comparison to the N-terminal domain of tissue inhibitor of metalloproteinases (TIMP).
|
| |
Mol Biosyst,
4,
417-425.
|
 |
|
|
|
|
 |
S.R.Van Doren,
S.Wei,
G.Gao,
B.B.DaGue,
M.O.Palmier,
H.Bahudhanapati,
and
K.Brew
(2008).
Inactivation of N-TIMP-1 by N-terminal acetylation when expressed in bacteria.
|
| |
Biopolymers,
89,
960-968.
|
 |
|
|
|
|
 |
V.Veverka,
T.Crabbe,
I.Bird,
G.Lennie,
F.W.Muskett,
R.J.Taylor,
and
M.D.Carr
(2008).
Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR.
|
| |
Oncogene,
27,
585-595.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.C.Waters,
V.Veverka,
M.Böhm,
T.Schmedt,
P.T.Choong,
F.W.Muskett,
K.H.Klempnauer,
and
M.D.Carr
(2007).
Structure of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4 and characterization of its interaction with eIF4A.
|
| |
Oncogene,
26,
4941-4950.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.Ravel,
G.Kister,
T.E.Malliavin,
and
M.A.Delsuc
(2007).
A general algorithm for peak-tracking in multi-dimensional NMR experiments.
|
| |
J Biomol NMR,
37,
265-275.
|
 |
|
|
|
|
 |
P.S.Renshaw,
K.L.Lightbody,
V.Veverka,
F.W.Muskett,
G.Kelly,
T.A.Frenkiel,
S.V.Gordon,
R.G.Hewinson,
B.Burke,
J.Norman,
R.A.Williamson,
and
M.D.Carr
(2005).
Structure and function of the complex formed by the tuberculosis virulence factors CFP-10 and ESAT-6.
|
| |
EMBO J,
24,
2491-2498.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.Bode,
and
K.Maskos
(2003).
Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
|
| |
Biol Chem,
384,
863-872.
|
 |
|
|
|
|
 |
M.H.Lee,
K.Maskos,
V.Knäuper,
P.Dodds,
and
G.Murphy
(2002).
Mapping and characterization of the functional epitopes of tissue inhibitor of metalloproteinases (TIMP)-3 using TIMP-1 as the scaffold: a new frontier in TIMP engineering.
|
| |
Protein Sci,
11,
2493-2503.
|
 |
|
|
|
|
 |
B.Stratmann,
M.Farr,
and
H.Tschesche
(2001).
Characterization of C-terminally truncated human tissue inhibitor of metalloproteinases-4 expressed in Pichia pastoris.
|
| |
Biol Chem,
382,
987-991.
|
 |
|
|
|
|
 |
L.Moschcovich,
S.Bernocco,
B.Font,
H.Rivkin,
D.Eichenberger,
N.Chejanovsky,
D.J.Hulmes,
and
E.Kessler
(2001).
Folding and activity of recombinant human procollagen C-proteinase enhancer.
|
| |
Eur J Biochem,
268,
2991-2996.
|
 |
|
|
|
|
 |
L.Y.Lian,
I.Barsukov,
A.P.Golovanov,
D.I.Hawkins,
R.Badii,
K.H.Sze,
N.H.Keep,
G.M.Bokoch,
and
G.C.Roberts
(2000).
Mapping the binding site for the GTP-binding protein Rac-1 on its inhibitor RhoGDI-1.
|
| |
Structure,
8,
47-55.
|
 |
|
|
|
|
 |
L.Bányai,
and
L.Patthy
(1999).
The NTR module: domains of netrins, secreted frizzled related proteins, and type I procollagen C-proteinase enhancer protein are homologous with tissue inhibitors of metalloproteases.
|
| |
Protein Sci,
8,
1636-1642.
|
 |
|
|
|
|
 |
L.Blavier,
P.Henriet,
S.Imren,
and
Y.A.Declerck
(1999).
Tissue inhibitors of matrix metalloproteinases in cancer.
|
| |
Ann N Y Acad Sci,
878,
108-119.
|
 |
|
|
|
|
 |
M.Hutton,
G.S.Butler,
B.A.Wattam,
F.Willenbrock,
R.A.Williamson,
and
G.Murphy
(1999).
Analysis of the interaction of TIMP-2 and MMPs: engineering the changes.
|
| |
Ann N Y Acad Sci,
878,
524-527.
|
 |
|
|
|
|
 |
W.Bode,
C.Fernandez-Catalan,
F.Grams,
F.X.Gomis-Rüth,
H.Nagase,
H.Tschesche,
and
K.Maskos
(1999).
Insights into MMP-TIMP interactions.
|
| |
Ann N Y Acad Sci,
878,
73-91.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |